iCell Cardiomyocytes

Find reliable and relevant human in vitro models essential for drug discovery, toxicity testing, and basic cardiac health and disease research. Derived from induced pluripotent stem cells (iPSCs), iCell^® Cardiomyocytes have proven advantages over other cellular cardiac models, enabling early and accurate prediction of drug-induced cardiotoxicity. These iPSC-derived cardiomyocytes faithfully reflect the endpoints of heart disease, facilitating the study of genetic, metabolic, and physiological contributing factors and advancing the search for cures.

• Gold standard With an industry-leading number of peer-reviewed publications and application protocols, iCell Cardiomyocytes are the in vitro model of choice.
• Consistent excellence Rigorous quality control processes and iPSC cardiomyocyte purity of >95% ensure reproducible results with every batch.
• Human relevance Terminally differentiated from human iPSCs, iCell Cardiomyocytes exhibit functional traits similar to native human cardiomyocytes, including synchronous beating (when seeded at appropriate densities).
• Versatile functionality From physiology to disease and cardiotoxicity to regenerative medicine, iCell Cardiomyocytes have extensive applicability in cardiac research.
• Simple implementation Specially formulated iCell media maximizes iPSC cardiomyocyte viability at thaw and beyond, enabling longer-term studies of ≤ 2 weeks.